These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 38699177)

  • 1. Orexins in apoptosis: a dual regulatory role.
    Cavalu S; Saber S; Hamad RS; Abdel-Reheim MA; Elmorsy EA; Youssef ME
    Front Cell Neurosci; 2024; 18():1336145. PubMed ID: 38699177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
    Hoyer D; Jacobson LH
    Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Orexin receptors: Structural and anti-tumoral properties.
    Couvineau A; Nicole P; Gratio V; Voisin T
    Front Endocrinol (Lausanne); 2022; 13():931970. PubMed ID: 35966051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orexins and their receptors: structural aspects and role in peripheral tissues.
    Voisin T; Rouet-Benzineb P; Reuter N; Laburthe M
    Cell Mol Life Sci; 2003 Jan; 60(1):72-87. PubMed ID: 12613659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases.
    Wang C; Wang Q; Ji B; Pan Y; Xu C; Cheng B; Bai B; Chen J
    Front Mol Neurosci; 2018; 11():220. PubMed ID: 30002617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of orexins in the central and peripheral regulation of glucose homeostasis: Evidences & mechanisms.
    Rani M; Kumar R; Krishan P
    Neuropeptides; 2018 Apr; 68():1-6. PubMed ID: 29472002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target.
    Alain C; Pascal N; Valérie G; Thierry V
    Molecules; 2021 Aug; 26(16):. PubMed ID: 34443437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression and protein distribution of orexins and orexin receptors in rat retina.
    Liu F; Xu GZ; Wang L; Jiang SX; Yang XL; Zhong YM
    Neuroscience; 2011 Aug; 189():146-55. PubMed ID: 21621592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OX2R-selective orexin agonism is sufficient to ameliorate cataplexy and sleep/wake fragmentation without inducing drug-seeking behavior in mouse model of narcolepsy.
    Yamamoto H; Nagumo Y; Ishikawa Y; Irukayama-Tomobe Y; Namekawa Y; Nemoto T; Tanaka H; Takahashi G; Tokuda A; Saitoh T; Nagase H; Funato H; Yanagisawa M
    PLoS One; 2022; 17(7):e0271901. PubMed ID: 35867683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexins and gastrointestinal functions.
    Baccari MC
    Curr Protein Pept Sci; 2010 Mar; 11(2):148-55. PubMed ID: 20353399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of orexin receptors in the regulation of sleep/wakefulness.
    Mieda M; Tsujino N; Sakurai T
    Front Endocrinol (Lausanne); 2013; 4():57. PubMed ID: 23730297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of orexin B and orexin-2 receptor in the rat epididymis.
    Liguori G; Tafuri S; Miyoshi C; Yanagisawa M; Squillacioti C; De Pasquale V; Mirabella N; Vittoria A; Costagliola A
    Acta Histochem; 2018 Apr; 120(3):292-297. PubMed ID: 29496265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin/hypocretin role in reward: implications for opioid and other addictions.
    Baimel C; Bartlett SE; Chiou LC; Lawrence AJ; Muschamp JW; Patkar O; Tung LW; Borgland SL
    Br J Pharmacol; 2015 Jan; 172(2):334-48. PubMed ID: 24641197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The orexin story, sleep and sleep disturbances.
    Pizza F; Barateau L; Dauvilliers Y; Plazzi G
    J Sleep Res; 2022 Aug; 31(4):e13665. PubMed ID: 35698789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.
    Han Y; Yuan K; Zheng Y; Lu L
    Neurosci Bull; 2020 Apr; 36(4):432-448. PubMed ID: 31782044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physiology and pharmacology of the orexins.
    Smart D; Jerman J
    Pharmacol Ther; 2002; 94(1-2):51-61. PubMed ID: 12191593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin receptors: multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders.
    Xu TR; Yang Y; Ward R; Gao L; Liu Y
    Cell Signal; 2013 Dec; 25(12):2413-23. PubMed ID: 23917208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal Regulation of the Orexin/Hypocretin System in Mice.
    Ventzke K; Oster H; Jöhren O
    Neuroscience; 2019 Nov; 421():59-68. PubMed ID: 31678347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiological role of orexins.
    Martynska L; Wolinska-Witort E; Chmielowska M; Bik W; Baranowska B
    Neuro Endocrinol Lett; 2005 Aug; 26(4):289-92. PubMed ID: 16135995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.